3.21.1 html 98 266 1 false 36 0 false 6 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.oricpharma.com/20210331/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - BALANCE SHEETS Sheet http://www.oricpharma.com/20210331/taxonomy/role/StatementBALANCESHEETS BALANCE SHEETS Statements 2 false false R3.htm 100020 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://www.oricpharma.com/20210331/taxonomy/role/StatementBALANCESHEETSParenthetical BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Sheet http://www.oricpharma.com/20210331/taxonomy/role/StatementSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Statements 4 false false R5.htm 100040 - Statement - STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) Sheet http://www.oricpharma.com/20210331/taxonomy/role/StatementSTATEMENTSOFCONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICITUnaudited STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) Statements 5 false false R6.htm 100050 - Statement - STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://www.oricpharma.com/20210331/taxonomy/role/StatementSTATEMENTSOFCASHFLOWSUnaudited STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 100060 - Disclosure - Description of the Business Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureDescriptionOfBusiness Description of the Business Notes 7 false false R8.htm 100070 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 100080 - Disclosure - License Agreements Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureLicenseAgreements License Agreements Notes 9 false false R10.htm 100090 - Disclosure - Property and Equipment, Net Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentNet Property and Equipment, Net Notes 10 false false R11.htm 100100 - Disclosure - Accrued Liabilities Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureAccruedLiabilities Accrued Liabilities Notes 11 false false R12.htm 100110 - Disclosure - Short-Term Investments Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureShortTermInvestments Short-Term Investments Notes 12 false false R13.htm 100120 - Disclosure - Fair Value Measurements Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 13 false false R14.htm 100130 - Disclosure - Equity Incentive Plans and Stock-Based Compensation Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureEquityIncentivePlansAndStockBasedCompensation Equity Incentive Plans and Stock-Based Compensation Notes 14 false false R15.htm 100140 - Disclosure - Commitments and Contingencies Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 100150 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.oricpharma.com/20210331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 16 false false R17.htm 100160 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://www.oricpharma.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentNet 17 false false R18.htm 100170 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureAccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://www.oricpharma.com/20210331/taxonomy/role/DisclosureAccruedLiabilities 18 false false R19.htm 100180 - Disclosure - Short-Term Investments (Tables) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureShortTermInvestmentsTables Short-Term Investments (Tables) Tables http://www.oricpharma.com/20210331/taxonomy/role/DisclosureShortTermInvestments 19 false false R20.htm 100190 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.oricpharma.com/20210331/taxonomy/role/DisclosureFairValueMeasurements 20 false false R21.htm 100200 - Disclosure - Equity Incentive Plans and Stock-Based Compensation (Tables) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureEquityIncentivePlansAndStockBasedCompensationTables Equity Incentive Plans and Stock-Based Compensation (Tables) Tables http://www.oricpharma.com/20210331/taxonomy/role/DisclosureEquityIncentivePlansAndStockBasedCompensation 21 false false R22.htm 100210 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.oricpharma.com/20210331/taxonomy/role/DisclosureCommitmentsAndContingencies 22 false false R23.htm 100220 - Disclosure - Description of the Business - Additional Information (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails Description of the Business - Additional Information (Details) Details 23 false false R24.htm 100230 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) Details 24 false false R25.htm 100240 - Disclosure - License Agreements - Additional Information (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetails License Agreements - Additional Information (Details) Details 25 false false R26.htm 100250 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Details 26 false false R27.htm 100260 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails Accrued Liabilities - Schedule of Accrued Liabilities (Details) Details 27 false false R28.htm 100270 - Disclosure - Short-Term Investments - Schedule of Cost, Gross Unrealized Holding Gains, Gross Unrealized Holding Losses and Fair Value of Available for Sale Investments (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureShortTermInvestmentsScheduleOfCostGrossUnrealizedHoldingGainsGrossUnrealizedHoldingLossesAndFairValueOfAvailableForSaleInvestmentsDetails Short-Term Investments - Schedule of Cost, Gross Unrealized Holding Gains, Gross Unrealized Holding Losses and Fair Value of Available for Sale Investments (Details) Details 28 false false R29.htm 100280 - Disclosure - Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details) Details 29 false false R30.htm 100290 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 30 false false R31.htm 100300 - Disclosure - Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureEquityIncentivePlansAndStockBasedCompensationAdditionalInformationDetails Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) Details 31 false false R32.htm 100310 - Disclosure - Equity Incentive Plans and Stock-Based Compensation - Summary of Option Activity (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureEquityIncentivePlansAndStockBasedCompensationSummaryOfOptionActivityDetails Equity Incentive Plans and Stock-Based Compensation - Summary of Option Activity (Details) Details 32 false false R33.htm 100320 - Disclosure - Equity Incentive Plans and Stock-Based Compensation - Summary of Outstanding Shares of Potential Dilutive Securities Excluded from Computation of Diluted Net Loss per Share (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureEquityIncentivePlansAndStockBasedCompensationSummaryOfOutstandingSharesOfPotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails Equity Incentive Plans and Stock-Based Compensation - Summary of Outstanding Shares of Potential Dilutive Securities Excluded from Computation of Diluted Net Loss per Share (Details) Details 33 false false R34.htm 100330 - Disclosure - Equity Incentive Plans and Stock-Based Compensation - Summary of Fair Value of Stock Options Estimated Using Black-Scholes Merton Option Pricing Model Assumptions (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureEquityIncentivePlansAndStockBasedCompensationSummaryOfFairValueOfStockOptionsEstimatedUsingBlackScholesMertonOptionPricingModelAssumptionsDetails Equity Incentive Plans and Stock-Based Compensation - Summary of Fair Value of Stock Options Estimated Using Black-Scholes Merton Option Pricing Model Assumptions (Details) Details 34 false false R35.htm 100340 - Disclosure - Equity Incentive Plans and Stock-Based Compensation - Summary of Total Stock-based Compensation Expense (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureEquityIncentivePlansAndStockBasedCompensationSummaryOfTotalStockBasedCompensationExpenseDetails Equity Incentive Plans and Stock-Based Compensation - Summary of Total Stock-based Compensation Expense (Details) Details 35 false false R36.htm 100350 - Disclosure - Commitment and Contingencies - Additional Information (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetails Commitment and Contingencies - Additional Information (Details) Details 36 false false R37.htm 100360 - Disclosure - Commitment and Contingencies - Summary of Future Lease Payments of Operating Lease Liabilities (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureLeasePaymentsOfOperatingLeaseLiabilitiesDetails Commitment and Contingencies - Summary of Future Lease Payments of Operating Lease Liabilities (Details) Details 37 false false R38.htm 100380 - Disclosure - Commitment and Contingencies - Summary of Future Minimum Lease Payments Under Non-cancelable Operating Leases (Details) Sheet http://www.oricpharma.com/20210331/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesDetails Commitment and Contingencies - Summary of Future Minimum Lease Payments Under Non-cancelable Operating Leases (Details) Details 38 false false All Reports Book All Reports oric-10q_20210331.htm oric-20210331.xsd oric-20210331_cal.xml oric-20210331_def.xml oric-20210331_lab.xml oric-20210331_pre.xml oric-ex311_26.htm oric-ex312_27.htm oric-ex321_28.htm oric-ex322_29.htm http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true